Viavi Solutions Inc. (VIAV)
NASDAQ: VIAV · Real-Time Price · USD
9.76
-0.29 (-2.89%)
At close: Aug 1, 2025, 4:00 PM
9.95
+0.19 (1.95%)
After-hours: Aug 1, 2025, 6:24 PM EDT

Theseus Pharmaceuticals Revenue

Viavi Solutions had revenue of $284.80M in the quarter ending March 29, 2025, with 15.77% growth. This brings the company's revenue in the last twelve months to $1.05B, up 3.34% year-over-year. In the fiscal year ending June 29, 2024, Viavi Solutions had annual revenue of $1.00B, down -9.56%.

Revenue (ttm)
$1.05B
Revenue Growth
+3.34%
P/S Ratio
2.08
Revenue / Employee
$290,500
Employees
3,600
Market Cap
2.18B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 29, 20241.00B-105.70M-9.56%
Jul 1, 20231.11B-186.30M-14.42%
Jul 2, 20221.29B93.50M7.80%
Jul 3, 20211.20B62.60M5.51%
Jun 27, 20201.14B6.00M0.53%
Jun 29, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jul 1, 2017 Pro Pro Pro
Jul 2, 2016 Pro Pro Pro
Jun 27, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.